King Pharmaceuticals KG GLS — Reverse for loss and loss adjustment expenses

Other product segments

Similar metrics at other companies

WTMHG Global — Loss and loss adjustment expense reserves

$0—

BH

BHLoss and loss adjustment expenses

$18.76M+4.3%

SLDELoss Adjustment Expense Reserves

$476.26M—

ROOTLoss and loss adjustment expense reserves

$472.7M+13.0%

TRVGeneral Liability — Claims and claim adjustment expense reserves

$16.77B+10.8%

SPNTInsurance & Services — Loss and loss adjustment expense reserves

$2B+31.0%

Questions, answered.

What is King Pharmaceuticals's GLS — reverse for loss and loss adjustment expenses?

King Pharmaceuticals (KG) reported GLS — reverse for loss and loss adjustment expenses of $9.86M in Q4 2025.

What does GLS — reverse for loss and loss adjustment expenses mean?

This represents the total estimated liability for claims that have been reported but not yet settled, including the associated costs to investigate and process those claims. It serves as a critical indicator of the segment's future cash outflow obligations related to insurance underwriting. Proper reserve adequacy is essential for maintaining long-term solvency and profitability.